Literature DB >> 11827037

The production of novel sordarin analogues by biotransformation.

R M Hall1, M J Dawson, C A Jones, A D Roberts, P J Sidebottom, P Stead, N L Taylor.   

Abstract

The biotransformation of the fungal protein synthesis inhibitor sordarin is reported. Nine taxonomically diverse organisms supported the isolation and identification of twelve modified products. The structural diversity of the biotransformation products observed and their value in supporting further chemistry is discussed.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11827037     DOI： 10.7164/antibiotics.54.948

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


  3 in total

1.  Bioconversion of FR901459, a novel derivative of cyclosporin A, by Lentzea sp. 7887.

Authors:  Satoshi Sasamura; Motoo Kobayashi; Hideyuki Muramatsu; Seiji Yoshimura; Takayoshi Kinoshita; Hidenori Ohki; Kazuki Okada; Yoko Deai; Yukiko Yamagishi; Michizane Hashimoto
Journal:  J Antibiot (Tokyo)       Date:  2015-03-18       Impact factor: 2.649

2.  Description of Streptomyces neopeptinius sp. nov., an actinobacterium with broad spectrum antifungal activities.

Authors:  Ji Hye Han; In Cheon Hwang; Sung Heun Cho; Cheol Jang; Nam Gyu Kim; Seung Hun Yu; Yong Man Yu; Seung Bum Kim
Journal:  J Microbiol       Date:  2008-07-05       Impact factor: 3.422

3.  Genome mining of the sordarin biosynthetic gene cluster from Sordaria araneosa Cain ATCC 36386: characterization of cycloaraneosene synthase and GDP-6-deoxyaltrose transferase.

Authors:  Fumitaka Kudo; Yasunori Matsuura; Takaaki Hayashi; Masayuki Fukushima; Tadashi Eguchi
Journal:  J Antibiot (Tokyo)       Date:  2016-04-13       Impact factor: 2.649
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.